Xeris Biopharma Holdings, Inc. (XERS)
6.02
-0.10
(-1.63%)
USD |
NASDAQ |
Mar 02, 16:00
6.00
-0.02
(-0.33%)
After-Hours: 07:35
Xeris Biopharma Holdings Accounts Payable (Quarterly) : 6.527M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 40.44M |
| IDEXX Laboratories, Inc. | 110.41M |
| Harrow, Inc. | 18.99M |
| Vir Biotechnology, Inc. | 9.803M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |